Table 2.
Baseline Characteristics of the Study Participants According to Treatment Assignment
| Characteristic | Total (n = 477) | Saccharomyces boulardii Group (n = 246) | Placebo Group (n = 231) |
|---|---|---|---|
| Age, years | 58.4 ± 17.2 | 60.1 ± 16.5 | 56.5 ± 17.8 |
| Male sex, no. (%) | 269 (56.4) | 140 (56.9) | 129 (55.8) |
| Body height, cm (mean ± SD) | 171.7 ± 9.7 | 171.8 ± 9.4 | 171.7 ± 10.0 |
| Body weight, kg (mean ± SD) | 83.0 ± 17.5 | 83.1 ± 17.0 | 83.0 ± 18.1 |
| Body mass index (mean ± SD) | 28.1 ± 5.4 | 28.1 ± 5.2 | 28.1 ± 5.6 |
| CRP (mg/L, mean ± SD) | 71.6 ± 93.9 | 71.0 ± 89.3 | 72.2 ± 98.9 |
| Leukocyte count (109/L, mean ± SD) | 10.8 ± 5.7 | 10.3 ± 4.6 | 11.4 ± 6.7 |
| Time under observation, days (mean ± SD) | 44.0 ± 22.4 | 44.1 ± 22.5 | 44.0 ± 22.3 |
| Duration of antibiotic treatment, days (mean ± SD) | 7.6 ± 6.5 | 7.9 ± 7.8 | 7.2 ± 4.9 |
Abbreviations: CRP, C-reactive protein; SD, standard deviation.